DendriNova Therapeutics AB

Active
559456-5169Limited company (AB)Registered 2023HÖLLVIKEN

Key figures

105 081 kr
Revenue 2025
050 k100 k150 k202320242025

Key figures

2025

Summary: DendriNova Therapeutics AB

What kind of company is it?

DendriNova Therapeutics AB (org. no. 559456-5169) is a limited company (AB). The company was registered in 2023 and has existed for 3 years. Registered seat: Höllviken.

How is the company doing financially?

Net sales in financial year 2025 were 105 081 kr. The company made a loss in all 3 reported financial years. According to the annual report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 124 456 kr and equity 22 737 kr (equity ratio 18,3 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2023–2025
202320242025
Sales revenue00105 081
Profit for the reporting year−2 26300
Retained earnings of previous periods———
Total assets272 737229 537124 456
Total liabilities250 000206 800101 719
Total equity22 73722 73722 737
Employees—00
Proposed dividend——0

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.